Fundamental dimension Equity attribute | CDNOLeader $0.00030.00% Cap $119.2KP/E -0.5x QuantScore43/100 | BLFRPeer $0.00730.00% Cap $247.8KP/E -0.1x QuantScore36/100 | CMOTPeer $0.00030.00% Cap $27.98KP/E -0.0x QuantScore29/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
55/100 |
66/100 |
52/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 50/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 50/100 | 30/100 | 20/100 |
Growth Revenue / earnings growth & margins | 0/100 | 0/100 | 46/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.5x | -0.1x | -0.0x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -1.0x | -0.2x | -1.5x |
Price / Sales | 178.3x | 11.6x | — |
Price / Free Cash Flow | 0.9x | 5.2x | -0.1x |
PEG ratio | -0.01 | -0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | — | 5 / 9 | 2 / 9 |
Altman Z-Score | — | -0.00 (Distress) | -72.95 (Distress) |
Total debt / equity | 0.00 | 0.15 | -0.56 |
Quick ratio | 0.5x | 0.1x | 0.1x |
Interest coverage | — | -53.8x | -15.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -99.3% | -5.5% | — |
Net income growth YoY | -30.6% | -2065.2% | +44.7% |
Gross margin (TTM) | 5.6% | -150.2% | 0.0% |
Operating margin (FY) | -18563.9% | -1050.1% | — |
FCF margin (FY) | 19113.7% | 224.4% | — |
5. Trailing price performancePrice change over period |
1M return | +200.0% | +30.4% | +2900.0% |
3M return | -0.0% | -75.7% | -0.0% |
6M return | -70.0% | -64.4% | -96.2% |
Year to date | -85.0% | -63.7% | -96.2% |
1Y return | -89.3% | -62.9% | -96.2% |
3Y return | -66.7% | -96.8% | -99.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.0004 +39.7% upside | — — | $-0.0097 -3321.6% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |